Christopher C. Caillouet

Array ( [id] => 9004399 [patent_doc_number] => 20130225524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'Chemical Compounds' [patent_app_type] => utility [patent_app_number] => 13/883023 [patent_app_country] => US [patent_app_date] => 2011-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75443 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739506 [patent_doc_number] => 20140275224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION' [patent_app_type] => utility [patent_app_number] => 13/883267 [patent_app_country] => US [patent_app_date] => 2011-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25175 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762603 [patent_doc_number] => 08846928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Benzamides and nicotinamides as Syk modulators' [patent_app_type] => utility [patent_app_number] => 13/287005 [patent_app_country] => US [patent_app_date] => 2011-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 98589 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13287005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160373 [patent_doc_number] => 20120101126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM' [patent_app_type] => utility [patent_app_number] => 13/280431 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4577 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101126.pdf [firstpage_image] =>[orig_patent_app_number] => 13280431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766093 [patent_doc_number] => 20120034187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Hepatitis C Inhibitor Compounds' [patent_app_type] => utility [patent_app_number] => 13/278532 [patent_app_country] => US [patent_app_date] => 2011-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35656 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034187.pdf [firstpage_image] =>[orig_patent_app_number] => 13278532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413687 [patent_doc_number] => 08697724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Crystalline oxalate salts of a diamide compound' [patent_app_type] => utility [patent_app_number] => 13/248840 [patent_app_country] => US [patent_app_date] => 2011-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 12928 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13248840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10154567 [patent_doc_number] => 09186318 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof' [patent_app_type] => utility [patent_app_number] => 14/345922 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 19234 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9345096 [patent_doc_number] => 08664244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Compounds as c-Met kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/227866 [patent_app_country] => US [patent_app_date] => 2011-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7651 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13227866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10594455 [patent_doc_number] => 09315530 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Adsorption of immunopotentiators to insoluble metal salts' [patent_app_type] => utility [patent_app_number] => 13/820370 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 33 [patent_no_of_words] => 37992 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670181 [patent_doc_number] => 20110319450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'BENZIMIDAZOLE COMPOUND CRYSTAL' [patent_app_type] => utility [patent_app_number] => 13/223988 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7285 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13223988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710890 [patent_doc_number] => 08835458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Quinoline or quinazoline derivatives with apoptosis inducing activity on cells' [patent_app_type] => utility [patent_app_number] => 13/818478 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37235 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791649 [patent_doc_number] => 20120053205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators' [patent_app_type] => utility [patent_app_number] => 13/218512 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27972 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053205.pdf [firstpage_image] =>[orig_patent_app_number] => 13218512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791650 [patent_doc_number] => 20120053206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators' [patent_app_type] => utility [patent_app_number] => 13/218579 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28544 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053206.pdf [firstpage_image] =>[orig_patent_app_number] => 13218579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791648 [patent_doc_number] => 20120053204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Substituted quinoline-3-carboxamides as KCNQ2/3 modulators' [patent_app_type] => utility [patent_app_number] => 13/218556 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27834 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053204.pdf [firstpage_image] =>[orig_patent_app_number] => 13218556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9034925 [patent_doc_number] => 20130237563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'NOVEL POLYMORPHS OF PITAVASTATIN CALCIUM' [patent_app_type] => utility [patent_app_number] => 13/884734 [patent_app_country] => US [patent_app_date] => 2011-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4723 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7652078 [patent_doc_number] => 20110301347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'BENZYL, AMINES, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS' [patent_app_type] => utility [patent_app_number] => 13/210173 [patent_app_country] => US [patent_app_date] => 2011-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31605 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301347.pdf [firstpage_image] =>[orig_patent_app_number] => 13210173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9989107 [patent_doc_number] => 09034303 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-19 [patent_title] => 'Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/816874 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 21297 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778613 [patent_doc_number] => 20120041024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'QUINOLYL AMINES AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/206706 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22960 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041024.pdf [firstpage_image] =>[orig_patent_app_number] => 13206706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355573 [patent_doc_number] => 08674107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Crystal of anti-bacterial compound' [patent_app_type] => utility [patent_app_number] => 13/814534 [patent_app_country] => US [patent_app_date] => 2011-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 5205 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355573 [patent_doc_number] => 08674107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Crystal of anti-bacterial compound' [patent_app_type] => utility [patent_app_number] => 13/814534 [patent_app_country] => US [patent_app_date] => 2011-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 5205 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814534 [rel_patent_id] =>[rel_patent_doc_number] =>)